Germline BAP1 mutations have been noted in several of these and other cancers such as meningioma, paraganglioma, basal cell carcinoma, ovarian cancers, and neuroendocrine tumors [21, 22]. This evidence concerns the gene BAP1 and neuroendocrine neoplasm.